Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches
Phase 2
Completed
- Conditions
- Migraine
- Interventions
- Other: Placebo (treatment C)Drug: DFN-15 Dose B (treatment B)Drug: DFN-15 Dose A (treatment A)
- First Posted Date
- 2015-06-15
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 63
- Registration Number
- NCT02472418
- Locations
- 🇺🇸
Clinvest/ A Division of Banyan Group, Inc., Springfield, Missouri, United States
🇺🇸California Medical Clinic for Headache, Santa Monica, California, United States
🇺🇸Collaborative Neuroscience Network, LLC, Long Beach, California, United States
Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed Conditions
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 46
- Registration Number
- NCT02322658
- Locations
- 🇮🇳
BA Research India Limited, Ahmedabad, Gujarat, India
Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 69
- Registration Number
- NCT02322632
- Locations
- 🇮🇳
Lambda Therapeutic Research Ltd, Ahmedabad, Gujarat, India
Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 46
- Registration Number
- NCT02322645
- Locations
- 🇮🇳
BA Research India Limited, Ahmedabad, Gujarat, India
Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 26
- Registration Number
- NCT02322619
Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer
- First Posted Date
- 2014-11-26
- Last Posted Date
- 2019-12-16
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 58
- Registration Number
- NCT02301962
- Locations
- 🇮🇳
DRL Investigational Site, New Delhi, India
Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition
- First Posted Date
- 2014-11-21
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 83
- Registration Number
- NCT02297854
- Locations
- 🇮🇳
Lambda Therapeutic Research Ltd, Ahmedabad, Gujrat, India
Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 66
- Registration Number
- NCT02296723
- Locations
- 🇮🇳
Lambda Therapeutic Research Ltd, Ahmedabad, Gujrat, India
Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT02296762
- Locations
- 🇮🇳
Bioserve Clinical Research Pvt. Ltd, Balanagar, Hyderabad, Andhra Pradesh, India
Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- Dr. Reddy's Laboratories Limited
- Target Recruit Count
- 60
- Registration Number
- NCT02296749
- Locations
- 🇮🇳
Bioserve Clinical Research Pvt. Ltd, Balanagar, Hyderabad, Andhra Pradesh, India
© Copyright 2025. All Rights Reserved by MedPath